Zurich Insurance Group Ltd FI Reduces Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Zurich Insurance Group Ltd FI trimmed its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 33.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,185,069 shares of the real estate investment trust’s stock after selling 598,144 shares during the period. Zurich Insurance Group Ltd FI’s holdings in Healthpeak Properties were worth $24,021,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Mizuho Bank Ltd. purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $28,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Healthpeak Properties in the fourth quarter valued at $30,000. Covestor Ltd raised its stake in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,152 shares during the period. Kestra Investment Management LLC purchased a new stake in Healthpeak Properties during the 4th quarter worth about $45,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in Healthpeak Properties during the 4th quarter worth about $46,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $17.49 on Wednesday. The company’s fifty day moving average price is $18.68 and its 200-day moving average price is $19.99. The firm has a market capitalization of $12.15 billion, a price-to-earnings ratio of 49.97, a PEG ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a one year low of $16.90 and a one year high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 earnings per share. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently declared a dividend, which will be paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th will be paid a dividend of $0.1017 per share. This represents a yield of 7.05%. The ex-dividend date is Monday, May 19th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 305.00%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, Director John T. Thomas acquired 4,200 shares of the stock in a transaction dated Monday, April 28th. The stock was purchased at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the acquisition, the director now owns 813,566 shares in the company, valued at $14,514,017.44. The trade was a 0.52% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Tommy G. Thompson acquired 5,700 shares of the business’s stock in a transaction dated Friday, May 9th. The stock was acquired at an average cost of $17.36 per share, with a total value of $98,952.00. Following the purchase, the director now directly owns 138,513 shares in the company, valued at $2,404,585.68. This represents a 4.29% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 23,987 shares of company stock worth $422,141. 0.23% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Evercore ISI reduced their target price on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Wedbush cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a research report on Monday, April 28th. Argus reaffirmed a “buy” rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Robert W. Baird decreased their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Tuesday, April 29th. Finally, StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Thursday, May 1st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $23.45.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.